Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.785
-0.095 (-1.95%)
Apr 25, 2025, 12:46 PM EDT - Market open
Avalo Therapeutics Employees
Avalo Therapeutics had 23 employees as of December 31, 2024. The number of employees increased by 4 or 21.05% compared to the previous year.
Employees
23
Change (1Y)
4
Growth (1Y)
21.05%
Revenue / Employee
$19,174
Profits / Employee
-$1,527,348
Market Cap
51.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
AVTX News
- 4 weeks ago - Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - GlobeNewsWire
- 4 weeks ago - Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside - Benzinga
- 5 weeks ago - Avalo Reports 2024 Financial Results and Recent Business Updates - GlobeNewsWire
- 2 months ago - Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Avalo Therapeutics to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 4 months ago - Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer - GlobeNewsWire
- 5 months ago - Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants - GlobeNewsWire
- 5 months ago - Avalo Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire